Although activation of Deaf1 could be beneficial in treatment of anxiety and depression, Deaf1 may also have beneficial actions on the immune system including enhancing responses to peripheral tissue antigens and to viral antigens (Yip et al., 2009; Ordureau et al., 2013). Here, DEAF1 is linked to depressive symptom measurement.